Efficacy and Safety of Losartan in Patients with Proteinuria
2002
The renoprotective effect and safety of an angiotensin II receptor blocker, losartan, were studied in 11 diabetic and 14 nondiabetic patients with a daily urinary protein excretion >500 mg. Once-daily
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
3
Citations
NaN
KQI